Skip to main content
Premium Trial:

Request an Annual Quote

Celera s Sequencing and Online Activities Slow to a Trickle Following Latest Round of Layoffs


Last week, Celera Genomics took one of its strongest steps away from the data-centric business model under which it was launched, releasing 16 percent, or 132, of its staff in the genome sequencing and online business units.

The move was was not a cost-cutting tactic, said company spokesman Rob Bennett. “The main objective is to align the organization around drug discovery activities,” he told BioInform’s sister publication, “That’s the big motivator here. This is not being driven by the need to take out cost.”

All Celera Genomics R&D staff will report to one new manager, who is currently being recruited. The company will retain limited staff in its genome sequencing department to complete its resequencing project and provide additional support to drug discovery efforts, Bennett said. In addition, more than 200 employees will remain to maintain the Celera Discovery System and related information products.

The company plans to add new staff to bolster its drug development activities, but further details of those plans are still unclear.

The restructuring impacts some of the senior scientific staff at Celera who contributed greatly to its sequencing projects.

Gene Myers, vice president of informatics research, will continue to run discovery informatics, but he and his group will move to Celera’s sister company, Applied Biosystems, which now distributes CDS.

Mark Adams, vice president for genome programs, will stay in the Celera informatics division but will refocus the group to study applications in drug discovery and development.

Ham Smith, senior scientist and director of DNA resources, will also stay with Celera and will be given “the creative latitude to decide which projects he wants to get involved in,” said Bennett.

John Reynders, VP of information systems, will focus on computing and analysis in support of the company’s proteomics research.

— BT

Filed under

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.